Publications by authors named "Jean B deKernion"

24Publications

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.

J Urol 2017 02 22;197(2S):S200-S207. Epub 2016 Dec 22.

Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri; Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Divisions of Urology and Hematology-Oncology, University of Arizona College of Medicine and Tucson Veterans Affairs Medical Center, Tucson, Arizona; Scott Department of Urology, Baylor College of Medicine, Houston, Texas; Department of Urology, Loyola University Medical Center, Chicago, Illinois; Division of Urology, UCLA School of Medicine, Los Angeles and Department of Clinical Research, Hybritech Incorporated, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.10.073DOI Listing
February 2017

Legends in urology.

Authors:
Jean B deKernion

Can J Urol 2011 Apr;18(2):5582-4

View Article

Download full-text PDF

Source
April 2011

In vivo imaging of intraprostatic-specific gene transcription by PET.

J Nucl Med 2011 May 15;52(5):784-91. Epub 2011 Apr 15.

Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.110.084582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173510PMC
May 2011

Ultrasound-based combination therapy: potential in urologic cancer.

Expert Rev Anticancer Ther 2011 Jan;11(1):107-13

Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.174DOI Listing
January 2011

Immunological therapy in urological malignancy: novel combination strategies.

Int J Urol 2011 Feb 12;18(2):94-101. Epub 2010 Nov 12.

Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-2042.2010.02664.xDOI Listing
February 2011

Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma.

J Urol 2008 Jan 19;179(1):338-45. Epub 2007 Nov 19.

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.08.094DOI Listing
January 2008

Society of Urologic Oncology: Whitmore lecture.

Authors:
Jean B deKernion

Urol Oncol 2006 Jul-Aug;24(4):318-21

Department of Urology, David Geffen School of Medicine, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2006.03.001DOI Listing
November 2006

Reexamination of current staging for renal cell carcinoma.

Authors:
Jean B deKernion

J Urol 2005 Mar;173(3):680

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000153986.96932.c8DOI Listing
March 2005

Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer.

Cancer Detect Prev 2004 ;28(5):368-74

Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cdp.2004.07.003DOI Listing
May 2005

Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.

Int J Cancer 2005 Mar;114(2):268-73

Department of Urology and Jonsson Comprehensive Cancer Center, 66-118 Center for Health Sciences, David Geffen School of Medicine at UCLA, Box 951738, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.20716
Publisher Site
http://dx.doi.org/10.1002/ijc.20716DOI Listing
March 2005

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy.

J Urol 2004 Jun;171(6 Pt 1):2260-4

Department of Urology, University of California-Los Angeles School of Medicine, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000127734.01845.99DOI Listing
June 2004

Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.

Cancer Epidemiol Biomarkers Prev 2004 Mar;13(3):383-90

Department of Epidemiology, School of Public Health, University of California-Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
March 2004

Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.

J Urol 2003 Mar;169(3):909-16

Kimmel Cancer Center, Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000045706.35470.1eDOI Listing
March 2003

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

J Clin Oncol 2002 Dec;20(23):4559-66

Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, CA 90095-1738, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.05.111DOI Listing
December 2002

Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.

J Urol 2002 Jul;168(1):110-5

Department of Urology, University of California Los Angeles School of Medicine and Veterans Administration Greater Los Angeles Healthcare System, 90095-1738, USA.

View Article

Download full-text PDF

Source
July 2002

Mathematical model to predict individual survival for patients with renal cell carcinoma.

J Clin Oncol 2002 Mar;20(5):1368-74

Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, CA 90095-1738, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.5.1368DOI Listing
March 2002

The Diagnosis and Treatment of Renal Cell Carcinoma.

Cancer 1980 Apr;45 Suppl 7:1947-1956

Fellow in Urologic Oncology, Tulane University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.1980.45.s7.1947DOI Listing
April 1980